Charles and Margaret Juravinski have turned the tables on the typical birthday tradition of receiving gifts. Instead, Margaret and Charles, who turned 91 on Nov. 1, chose to give a gift – a new investment of $3 million to support health research through the Juravinski Research Institute.
A newly expanded unit for patients needing treatment for blood cancers such as lymphoma and leukemia officially opened at Juravinski Hospital and Cancer Centre on October 30, 2020.
“The newest form of cellular therapy we’re conducting is CAR (Chimeric Antigen Receptor) T-cell therapy,” explains Dr. Tom Kouroukis. “We were privileged to be one of the first two sites for adult CAR T-cell therapy in Canada.”
Providing inclusive and effective health care involves understanding and respecting the needs of diverse cultures. That is one reason why the Indigenous Cancer Care Program at Juravinski Cancer Centre is so important.
Greater understanding. Innovative thinking. New points of view. These are some of the outcomes when the Patient and Family Advisory Council (PFAC) at Juravinski Hospital and Cancer Centre holds its bi-monthly meetings.
To ensure that the needs of the entire family are met, a donor-funded pilot study is aiming to improve the quality of life for cancer patients by addressing the needs of their children.
Cyndy McLean was diagnosed with colon cancer, which had metastasized to her liver. After surgery was conducted, a follow-up scan determined that additional treatment was necessary.
Autologous transplants (which use a patient’s own stem cells), are collected from a patient and infused at a later date. The Stem Cell Laboratory plays a vital role in preserving these stem cells.
Donor-funded research is exploring the use of a 3D printer to enhance care for patients with head and neck cancers.
The Rapid Evaluation and Symptom Support Cancer Unit (RESSCU) is an urgent cancer care centre at Juravinski Hospital and Cancer Centre.